A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|9|1056-1085

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.9, 2015-03, pp. : 1056-1085

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

β-Amyloid peptide as a target for treatment of Alzheimer’s disease

By Conde Santiago  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 503-512

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Amyloid-&bgr; Aggregation in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1223-1243

Bentham Science Publishers

Access to resources Recommend Favorite

Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012)

By Belluti Federica   Rampa Angela   Gobbi Silvia   Bisi Alessandra  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 581-596

Informa Healthcare

Access to resources Recommend Favorite

Amyloid-&bgr; Immunotherapy for Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-04 ,pp. : 197-206

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 13, 2015-09 ,pp. : 1110-1121

Bentham Science Publishers

Access to resources Recommend Favorite